Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells.
Journal Article (Journal Article)
The concept that human cancer is in essence a genetic disease driven by gene mutations has been well established, yet its utilization in functional studies of cancer genes has not been fully explored. Here, we describe a simple genetics-based approach that can quickly and sensitively reveal the effect of the alteration of a gene of interest on the fate of its host cells within a heterogeneous population, essentially monitoring the genetic selection that is associated with and powers the tumorigenesis. Using this approach, we discovered that loss-of-function of TP53 can promote the development of resistance of castration in prostate cancer cells via both transiently potentiating androgen-independent cell growth and facilitating the occurrence of genome instability. The study thus reveals a novel genetic basis underlying the development of castration resistance in prostate cancer cells and provides a facile genetic approach for studying a cancer gene of interest in versatile experimental conditions.
Full Text
Duke Authors
Cited Authors
- Lei, K; Sun, R; Chen, LH; Diplas, BH; Moure, CJ; Wang, W; Hansen, LJ; Tao, Y; Chen, X; Chen, C-PJ; Greer, PK; Zhao, F; Yan, H; Bigner, DD; Huang, J; He, Y
Published Date
- August 21, 2018
Published In
Volume / Issue
- 8 / 1
Start / End Page
- 12507 -
PubMed ID
- 30131529
Pubmed Central ID
- PMC6104024
Electronic International Standard Serial Number (EISSN)
- 2045-2322
Digital Object Identifier (DOI)
- 10.1038/s41598-018-30062-z
Language
- eng
Conference Location
- England